Health
Medical
Pharmaceutical
OptiNose
$8.179876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.51 (-5.88%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell OptiNose and other stocks, options, ETFs, and crypto commission-free!
About
OptiNose, Inc. Common Stock, also called OptiNose, is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Read More Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in May 2010 and is headquartered in Yardley, PA.
Employees
102
Headquarters
Yardley, Pennsylvania
Founded
2010
Market Cap
358.18M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
246.42K
High Today
$8.64
Low Today
$8.06
Open Price
$8.57
Volume
51.00K
52 Week High
$30.00
52 Week Low
$5.66
Collections
Health
Medical
Pharmaceutical
2017 IPO
US
North America
Price Paid on Robinhood
37% Lower
Right Now
52 Week Low
$5.66
Average Price Paid
$13.02
52 Week High
$30.00
Earnings
-$4.23
-$2.99
-$1.74
-$0.50
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.71 per share
Actual
-$0.70 per share